Tabletop blood count developer Sight raises $27.8M in series C by Conor Hale Thursday, February 14, 2019 Sight Diagnostics, maker of point-of-care blood diagnostic hardware, raised $27.8 million to continue its expansion and fund U.S. regulatory efforts.
Magnolia Medical nets $20M for its blood sample isolation system by Conor Hale Thursday, January 31, 2019 Magnolia Medical Technologies raised $20 million in VC funding to scale up production of its Steripath device for reducing blood draw contamination.
Tyto Care pulls in a total of $33.5M in series C by Conor Hale Friday, January 18, 2019 Telehealth equipment maker Tyto Care raised an extra $9 million through its series C round, bringing its total up to $33.5 million.
Synthetic biology manufacturer Zymergen raises another $400M by Conor Hale Friday, December 14, 2018 Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology platform.
Telehealth firm 98point6 nets $50M in round led by Goldman Sachs by Conor Hale Tuesday, October 30, 2018 98point6, which makes primary care doctors available over cellphone messages, raised $50 million in a financing round led by Goldman Sachs.
MeMed raises $70M for immune system-based infection diagnostics by Conor Hale Friday, September 21, 2018 MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
XACT nets CE mark, $5M for its robot-guided needle surgery probe by Conor Hale Friday, September 14, 2018 XACT Robotics raised $5 million alongside a CE mark for its integrated robotic system for image-guided, needle-puncture procedures, such as biopsies.
Rakuten Aspyrian nets $150M to fund cancer photoimmunotherapies by Conor Hale Thursday, August 23, 2018 Rakuten Aspyrian raised $150 million to fund a phase 3 trial of its photoimmunotherapy platform in head and neck cancer.
Profusa nets $45M to sell implanted tissue oxygen sensors by Conor Hale Tuesday, August 14, 2018 Profusa raised more than $45 million in a series C round for its tissue-integrated biosensors.
Akili collects $13M ahead of FDA verdict on digital ADHD therapy by Conor Hale Thursday, August 9, 2018 Akili brought its series C total up to $68 million while it awaits an FDA decision on its prescription video game for pediatric ADHD.